MAI Capital Management’s AbbVie ABBV Stock Holding History

MAI Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300	Closed	-$32K	–	801
2021 Q1	$32K	Buy	+300	New	+$32.1K	﹤0.01%	725
2019 Q4	–	Sell	-8,100	Closed	-$613K	–	592
2019 Q3	$613K	Hold	8,100	–	–	0.03%	324
2019 Q2	$589K	Hold	8,100	–	–	0.03%	329
2019 Q1	$653K	Buy	+8,100	New	+$663K	0.03%	269

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MAI Capital Management's ABBV Position: Q1 2026 in Review

MAI Capital Management increased its AbbVie (ABBV) stake by 0.31% in Q1 2026, buying an estimated $392K and bringing the position to 577,833 shares worth $126M. The position accounts for 0.71% of the portfolio, ranked #29.

MAI Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $132M in Q4 2025. 4,074 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

MAI Capital Management held 577,833 shares of AbbVie worth $126M as of Q1 2026.
MAI Capital Management bought 1,766 AbbVie shares in Q1 2026, an estimated $392K.
AbbVie made up 0.71% of MAI Capital Management's portfolio in Q1 2026, its #29 holding.
MAI Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
MAI Capital Management's AbbVie position peaked at $132M in Q4 2025.
4,074 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.